Skip to main content
Carisma Therapeutics, Inc. (CARM)
OTCMKTS · Delayed Price · Currency is USD
0.0530
+0.0045 (9.28%)
At close: Dec 5, 2025

Carisma Therapeutics Revenue

Carisma Therapeutics had revenue of $45.25M in the quarter ending September 30, 2025, with 1,236.78% growth. This brings the company's revenue in the last twelve months to $52.63M, up 159.68% year-over-year. In the year 2024, Carisma Therapeutics had annual revenue of $19.63M with 31.59% growth.

Revenue (ttm)
52.63M
Revenue Growth
+159.68%
P/S Ratio
0.04
Revenue / Employee
1.14M
Employees
46
Market Cap
2.22M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202419.63M4.71M31.59%
Dec 31, 202314.92M5.09M51.71%
Dec 31, 20229.83M--
Dec 31, 2021---
Dec 31, 2020---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Veradigm 588.02M
Elite Pharmaceuticals 122.89M
Glass House Brands 196.17M
American Oncology Network 1.76B
Northwest Biotherapeutics 937.00K
Silence Therapeutics 25.83M
Global Cord Blood 196.10M
Zomedica 29.45M
Revenue Rankings

Carisma Therapeutics News

More News